Q-omics provides the consensus-scored LINC01944 profile across patient tissues and cancer cell-line models. LINC01944 expression is associated with patient survival in 12 of 34 cancer types, with the highest sampling consensus in UCS. Among the 18 cancer types available for tumor–normal comparison, LINC01944 is differentially expressed in 3, with the highest sampling consensus in KICH. Additionally, LINC01944 RNA expression shows 6,823 significant gene co-expression associations, with the highest sampling consensus in SARC. Together, these results highlight UCS, KICH, and SARC as cancer lineages where LINC01944 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01944 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01944 survival associations across molecular data types. LINC01944 RNA expression shows survival associations in the most cancer types (12). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01944 RNA expression–survival associations across cancer types. High LINC01944 expression shows unfavorable associations in KIRP, SKCM, MESO, LUAD and COAD, but favorable associations in UCS. The UCS Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify UCS as the clearest survival context for LINC01944 RNA expression.
This table summarizes LINC01944 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 3. The strongest signals are observed in KICH for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01944. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01944 shows lower tumor expression in KICH and higher tumor expression in LUSC and HNSC. The KICH box plot shows higher LINC01944 RNA expression in normal versus tumor tissue (log2 FC = −0.186, t-test p < 0.001).
This table shows molecular features associated with LINC01944 in patient tissues and cancer cell lines. In patient samples, LINC01944 shows the broadest associations at the RNA and protein expression levels, with SARC recurring as the lineage with the largest associated feature set.
